Chicago-based Advanced Life Sciences to be showcased
at prestigious equity conferences
Woodridge, Ill, October 1, 2002 - Advanced Life Sciences, Inc.
(ALS) will be participating in two highly prestigious equity conferences,
both taking place today, announced Michael T. Flavin, Ph.D., ALS's
Chief Executive Officer.
Biotechnology Industry Organization (BIO) selected ALS as one
of the biotechnology companies who will be showcased at BIO VentureForum
2002 at the Palace Hotel in San Francisco today and tomorrow.
An advisor panel of 41 healthcare venture firms selected ALS from
more than 350 applicants. The presenting companies represent 25
states and six countries.
In addition, William Blair & Co. has invited ALS to present
at that company's Fifth Annual Private Equity Conference at the
Four Seasons Hotel in Chicago. William Blair & Company anticipates
that representatives more than 200 private equity firms will attend.
"Advanced Life Sciences acknowledges the recognition of having
been chosen to present as these two elite conferences," said
Flavin. "We believe that our formula of securing the best
products for investigation, the smartest people and the most efficient
process is paying off for our company and our investors.
Advanced Life Sciences is a privately held biopharmaceutical company
engaged in the discovery, development and commercialization of
novel drugs in the therapeutic areas of infection, cancer, and
inflammation using its platform in natural products and chemical
proteomics coupled with expertise in drug development. (www.advancedlifesciences.com)